AIM
Price
$0.29
Change
+$0.02 (+7.41%)
Updated
Aug 7, 04:47 PM (EDT)
Capitalization
7.51M
11 days until earnings call
Intraday BUY SELL Signals
LEGN
Price
$20.42
Change
+$1.14 (+5.91%)
Updated
Aug 7, 02:00 PM (EDT)
Capitalization
3.73B
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AIM vs LEGN

AIM vs LEGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AIM vs. LEGN commentary
Aug 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and LEGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2026
Stock price -- (AIM: $0.27 vs. LEGN: $19.28)
Brand notoriety: AIM and LEGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 58% vs. LEGN: 41%
Market capitalization -- AIM: $7.51M vs. LEGN: $3.73B
AIM [@Biotechnology] is valued at $7.51M. LEGN’s [@Biotechnology] market capitalization is $3.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $122.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 1 FA rating(s) are green whileLEGN’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 1 green, 4 red.
  • LEGN’s FA Score: 1 green, 4 red.
According to our system of comparison, LEGN is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 4 TA indicator(s) are bullish while LEGN’s TA Score has 4 bullish TA indicator(s).

  • AIM’s TA Score: 4 bullish, 4 bearish.
  • LEGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AIM is a better buy in the short-term than LEGN.

Price Growth

AIM (@Biotechnology) experienced а +15.23% price change this week, while LEGN (@Biotechnology) price change was +1.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.94%. For the same industry, the average monthly price growth was +0.31%, and the average quarterly price growth was +2915.40%.

Reported Earning Dates

AIM is expected to report earnings on Aug 18, 2026.

LEGN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+6.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($3.73B) has a higher market cap than AIM($7.51M). LEGN YTD gains are higher at: -11.316 vs. AIM (-76.011). AIM has higher annual earnings (EBITDA): -12.09M vs. LEGN (-175.3M). LEGN has more cash in the bank: 835M vs. AIM (5.88M). AIM has less debt than LEGN: AIM (4.57M) vs LEGN (389M). LEGN has higher revenues than AIM: LEGN (1.14B) vs AIM (94K).
AIMLEGNAIM / LEGN
Capitalization7.51M3.73B0%
EBITDA-12.09M-175.3M7%
Gain YTD-76.011-11.316672%
P/E RatioN/AN/A-
Revenue94K1.14B0%
Total Cash5.88M835M1%
Total Debt4.57M389M1%
FUNDAMENTALS RATINGS
AIM vs LEGN: Fundamental Ratings
AIM
LEGN
OUTLOOK RATING
1..100
2450
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9065
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AIM's Valuation (30) in the null industry is in the same range as LEGN (31). This means that AIM’s stock grew similarly to LEGN’s over the last 12 months.

AIM's Profit vs Risk Rating (100) in the null industry is in the same range as LEGN (100). This means that AIM’s stock grew similarly to LEGN’s over the last 12 months.

LEGN's SMR Rating (98) in the null industry is in the same range as AIM (100). This means that LEGN’s stock grew similarly to AIM’s over the last 12 months.

LEGN's Price Growth Rating (65) in the null industry is in the same range as AIM (90). This means that LEGN’s stock grew similarly to AIM’s over the last 12 months.

LEGN's P/E Growth Rating (100) in the null industry is in the same range as AIM (100). This means that LEGN’s stock grew similarly to AIM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMLEGN
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AIM
Daily Signal:
Gain/Loss:
LEGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUSK2.940.09
+3.16%
Mammoth Energy Services
HAE85.021.42
+1.70%
Haemonetics Corp
ADXN5.52-0.01
-0.18%
Addex Therapeutics Ltd
HIVE2.76-0.08
-2.82%
HIVE Digital Technologies Ltd
AMRZ51.22-1.66
-3.14%
AMRIZE AG

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
+1.21%
AXON - LEGN
37%
Loosely correlated
-14.28%
AMLX - LEGN
35%
Loosely correlated
+10.71%
WVE - LEGN
31%
Poorly correlated
+1.52%
AMRN - LEGN
31%
Poorly correlated
-1.04%
AIM - LEGN
30%
Poorly correlated
-4.51%
More